420 related articles for article (PubMed ID: 18613842)
1. Development of TLR inhibitors for the treatment of autoimmune diseases.
Barrat FJ; Coffman RL
Immunol Rev; 2008 Jun; 223():271-83. PubMed ID: 18613842
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Krieg AM; Vollmer J
Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
[TBL] [Abstract][Full Text] [Related]
3. [Role of TLR-dependent and independent pathways in autoimmunity].
Kumagai Y; Akira S
Nihon Rinsho; 2009 Mar; 67(3):487-93. PubMed ID: 19280921
[TBL] [Abstract][Full Text] [Related]
4. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
Lin Q; Li M; Fang D; Fang J; Su SB
Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
[TBL] [Abstract][Full Text] [Related]
5. The role of innate immunity in autoimmune tissue injury.
Allam R; Anders HJ
Curr Opin Rheumatol; 2008 Sep; 20(5):538-44. PubMed ID: 18698174
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid recognition receptors in autoimmunity.
Krug A
Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658
[TBL] [Abstract][Full Text] [Related]
7. The role of innate immune responses in autoimmune disease development.
Waldner H
Autoimmun Rev; 2009 Mar; 8(5):400-4. PubMed ID: 19162250
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid recognizing Toll-like receptors and autoimmunity.
von Landenberg P; Bauer S
Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
[TBL] [Abstract][Full Text] [Related]
9. Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus.
Anders HJ; Krug A; Pawar RD
Eur J Immunol; 2008 Jul; 38(7):1795-9. PubMed ID: 18581336
[TBL] [Abstract][Full Text] [Related]
10. TLR9 and the recognition of self and non-self nucleic acids.
Lamphier MS; Sirois CM; Verma A; Golenbock DT; Latz E
Ann N Y Acad Sci; 2006 Oct; 1082():31-43. PubMed ID: 17145922
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors: emerging concepts in kidney disease.
Anders HJ; Schlöndorff D
Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
[TBL] [Abstract][Full Text] [Related]
12. Endogenous TLR ligands and autoimmunity.
Wagner H
Adv Immunol; 2006; 91():159-73. PubMed ID: 16938540
[TBL] [Abstract][Full Text] [Related]
13. The role of innate immunity in the induction of autoimmunity.
Pisetsky DS
Autoimmun Rev; 2008 Oct; 8(1):69-72. PubMed ID: 18708168
[TBL] [Abstract][Full Text] [Related]
14. TLRs and chronic inflammation.
Ospelt C; Gay S
Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors on the fork roads between innate and adaptive immunity.
Abdelsadik A; Trad A
Hum Immunol; 2011 Dec; 72(12):1188-93. PubMed ID: 21920397
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors, endogenous ligands, and systemic autoimmune disease.
Rifkin IR; Leadbetter EA; Busconi L; Viglianti G; Marshak-Rothstein A
Immunol Rev; 2005 Apr; 204():27-42. PubMed ID: 15790348
[TBL] [Abstract][Full Text] [Related]
17. Innate immunity in systemic lupus erythematosus: sensing endogenous nucleic acids.
Kontaki E; Boumpas DT
J Autoimmun; 2010 Nov; 35(3):206-11. PubMed ID: 20638241
[TBL] [Abstract][Full Text] [Related]
18. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
19. Accessing the therapeutic potential of immunostimulatory nucleic acids.
Barchet W; Wimmenauer V; Schlee M; Hartmann G
Curr Opin Immunol; 2008 Aug; 20(4):389-95. PubMed ID: 18652893
[TBL] [Abstract][Full Text] [Related]
20. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
Barrat FJ; Meeker T; Gregorio J; Chan JH; Uematsu S; Akira S; Chang B; Duramad O; Coffman RL
J Exp Med; 2005 Oct; 202(8):1131-9. PubMed ID: 16230478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
